Home » Diseases » Corneal Neovascularization: Disease Bioinformatics
Submit your image related to Diseases to be featured!
Submit an Image

Get Social

Submit your Twitter account related to Corneal Neovascularization to be featured!
Submit an Account

Blogs

 Submit your blog on Corneal Neovascularization to be featured!
Submit a Blog

Events

 Submit your event on Corneal Neovascularization to be featured!
Submit an Event

Videos

Submit your video on Corneal Neovascularization to be featured!
Submit a Video

Charities

Submit your charity on Corneal Neovascularization to be featured!
Submit a Charity

Corneal Neovascularization: Disease Bioinformatics

Research of Corneal Neovascularization has been linked to Pathologic Neovascularization, Corneal Diseases, Tumor Angiogenesis, Keratitis, Inflammation. The study of Corneal Neovascularization has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Corneal Neovascularization include Angiogenesis, Pathogenesis, Lymphangiogenesis, Wound Healing, Cell Proliferation. These pathways complement our catalog of research reagents for the study of Corneal Neovascularization including antibodies and ELISA kits against VEGFA, FGF2, BASIC FIBROBLAST GROWTH FACTOR, PECAM1, HBA1.

Top Research Reagents

We have 6427 products for the study of Corneal Neovascularization that can be applied to Chromatin Immunoprecipitation (ChIP), Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.

Plasminogen Antibody
NB600-930
Western Blot: Plasminogen Antibody [NB600-930] - Lane 1: Plasminogen. Lane 2: None. Load: 50 ng per lane. Primary antibody: Plasminogen primary antibody at 1:1,000 overnight at 4C. Secondary antibody: Peroxidase goat secondary antibody at 1:40,000 for 60 min at RT. Blocking: incubated with blocking buffer for 30 min at RT. Predicted/Observed size: 91 kDa, 91 kDa for Plasminogen. Other band(s): None.Western Blot: Plasminogen Antibody [NB600-930] - Detection of Plasminogen under reducing (R) and non-reducing (NR) conditions. Reduced samples of purified target proteins contained 4% BME and were boiled for 5 minutes. Samples of 1ug of protein per lane were run by SDS-PAGE. Protein was transferred to nitrocellulose and probed with 1:3000 dilution of primary antibody. Detection shown was using Dylight 649 conjugated Donkey anti goat 1 hr RT.

Goat Polyclonal
Species Human, Rat
Applications WB, ELISA

     2 Reviews

6 Publications
Hemoglobin alpha Antibody - BSA Free
NB110-41083

Goat Polyclonal
Species Human
Applications WB, ELISA, ICC/IF

12 Publications
VEGFR2/KDR/Flk-1 Antibody [Unconjugated]
AF644
VEGFR2/KDR/Flk-1 was detected in immersion fixed frozen sections of mouse embryo (14 d.p.c.) using 15 µg/mL Goat Anti-Mouse VEGFR2/KDR/Flk-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF644) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # <a class=VEGFR2 was detected in acetone fixed cryosections of mouse kidney tissue using Goat Anti-Mouse VEGFR2/KDR/Flk-1 Polyclonal Antibody (Catalog # AF644) for 50 minutes at room temperature. Tissues were stained with rabbit anti-goat secondary<br>antibody and HRP polymer-conjugated anti-rabbit IgG followed by AEC+Substrate Chromogen (red) followed by counterstaining with hematoxylin (blue). Experiments were carried out and the image was provided by Dr. Grietje Molema, University Medical Center Groningen, The Netherlands.

Goat Polyclonal
Species Mouse
Applications WB, Flow, IHC

     3 Reviews

97 Publications
LYVE-1 Antibody [Unconjugated]
AF2125
LYVE-1 was detected in perfusion fixed frozen sections of mouse liver using 15 µg/mL Goat Anti-Mouse LYVE-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2125) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; <a class=Western blot shows lysates of mouse liver tissue and bEnd.3 mouse brain endothelial cell line. PVDF membrane was probed with 0.25 µg/mL of Goat Anti-Mouse LYVE-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF2125) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (<a class=

Goat Polyclonal
Species Mouse
Applications WB, IHC, Dual ISH-IHC

     1 Review

133 Publications
CD31/PECAM-1 Antibody [Unconjugated]
AF3628
Western blot shows lysates of bEnd.3 mouse endothelioma cell line. PVDF membrane was probed with 0.5 µg/mL of Goat Anti-Human/Mouse/Rat CD31/PECAM-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3628) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (<a class=Mouse splenocytes were stained with Goat Anti-Human/Mouse/Rat CD31/PECAM-1 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3628, filled histogram) or control antibody (<a class=

Goat Polyclonal
Species Human, Mouse, Rat
Applications WB, Flow, IHC

     6 Reviews

476 Publications
Serpin F1/PEDF [Biotin]
DY1177-05
N/A Serpin F1/PEDF [Biotin]


Species Human
Applications ELISA

18 Publications
Thrombospondin-1 [HRP]
DTSP10
N/A Thrombospondin-1 [HRP]


Species Human
Applications ELISA

38 Publications
VEGF [HRP]
DVE00
N/A VEGF [HRP]N/A VEGF [HRP]


Species Human
Applications ELISA

674 Publications
MMP-9 [HRP]
DMP900
N/A MMP-9 [HRP]N/A MMP-9 [HRP]


Species Human
Applications ELISA

219 Publications
TNF-alpha [Unconjugated]
210-TA
Recombinant Human TNF-alpha (Catalog # 210-TA) has a molecular weight (MW) of 53.1 kDa as analyzed by SEC-MALS, suggesting that this protein is a homotrimer.  MW may differ from predicted MW due to post-translational modifications (PTMs) present (i.e. Glycosylation).Recombinant Human TNF-alpha (Catalog # 210‑TA) induces cytotoxicity in the L-929 mouse fibroblast cell line in the presence of the metabolic inhibitor actinomycin D. The ED<sub>50</sub> for this effect is 25‑100 pg/mL.


Species Human
Applications BA

     3 Reviews

807 Publications
MMP-2 [HRP]
MMP200
N/A MMP-2 [HRP]N/A MMP-2 [HRP]


Species Human, Mouse, Rat
Applications ELISA

101 Publications
FGF basic/FGF2/bFGF [Unconjugated]
233-FB


Species Human
Applications BA

531 Publications
Angiopoietin-2 [HRP]
DANG20
N/A Angiopoietin-2 [HRP]N/A Angiopoietin-2 [HRP]


Species Human
Applications ELISA

102 Publications
Endostatin [HRP]
DNST0
N/A Endostatin [HRP]N/A Endostatin [HRP]


Species Human
Applications ELISA

22 Publications
VEGF-C [HRP]
DVEC00
N/A VEGF-C [HRP]N/A VEGF-C [HRP]


Species Human
Applications ELISA

53 Publications
VEGFR1/Flt-1 [HRP]
DVR100C
N/A VEGFR1/Flt-1 [HRP]N/A VEGFR1/Flt-1 [HRP]


Species Human
Applications ELISA

85 Publications

Related Genes

Corneal Neovascularization has been researched against:

Related Pathways

Corneal Neovascularization has been linked to:

Related Diseases

Corneal Neovascularization has been studied in relation to diseases such as:

Related PTMs

Corneal Neovascularization has been studied in relation to posttranslational modifications (PTMs) including:

Alternate Names

Corneal Neovascularization is also known as corneal neovascularization, unspecified corneal neovascularization (disorder), corneal neovascularization nos (disorder), corneal neovascularization, unspecified, corneal neovascularization (disorder).